	US 12,233,154 B2
	Compositions for sensitive skin
David Gan, Southlake, TX (US); Tiffany Carle, Dallas, TX (US); Michelle Hines, Hickory Creek, TX (US); Milagros Sanchez, Dallas, TX (US); Patricia Jacoby, Dallas, TX (US); and Linda Hart, Dallas, TX (US)
Assigned to MARY KAY INC, Addison, TX (US)
Filed by MARY KAY INC., Addison, TX (US)
Filed on Nov. 28, 2023, as Appl. No. 18/521,113.
Application 18/521,113 is a continuation of application No. 18/085,012, filed on Dec. 20, 2022, granted, now 11,865,204.
Application 18/085,012 is a continuation of application No. 16/919,825, filed on Jul. 2, 2020, granted, now 11,559,480, issued on Jan. 24, 2023.
Application 16/919,825 is a continuation of application No. 16/234,028, filed on Dec. 27, 2018, granted, now 10,736,837, issued on Aug. 11, 2020.
Application 16/234,028 is a continuation of application No. 15/796,958, filed on Oct. 30, 2017, granted, now 10,245,282, issued on Apr. 2, 2019.
Application 15/796,958 is a continuation of application No. 14/550,664, filed on Nov. 21, 2014, granted, now 9,801,900, issued on Oct. 31, 2017.
Claims priority of provisional application 61/921,803, filed on Dec. 30, 2013.
Claims priority of provisional application 61/913,551, filed on Dec. 9, 2013.
Claims priority of provisional application 61/907,836, filed on Nov. 22, 2013.
Prior Publication US 2024/0207170 A1, Jun. 27, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 9/00 (2006.01); A61K 8/63 (2006.01); A61K 8/64 (2006.01); A61K 8/73 (2006.01); A61K 8/97 (2017.01); A61K 8/9711 (2017.01); A61K 8/9789 (2017.01); A61K 8/9794 (2017.01); A61K 9/06 (2006.01); A61K 9/107 (2006.01); A61K 31/704 (2006.01); A61K 31/734 (2006.01); A61K 36/23 (2006.01); A61K 36/28 (2006.01); A61K 36/33 (2006.01); A61K 36/88 (2006.01); A61K 36/896 (2006.01); A61K 38/01 (2006.01); A61K 38/16 (2006.01); A61Q 19/00 (2006.01); A61Q 19/08 (2006.01)

CPC A61K 9/0014 (2013.01) [A61K 8/63 (2013.01); A61K 8/64 (2013.01); A61K 8/73 (2013.01); A61K 8/733 (2013.01); A61K 8/97 (2013.01); A61K 8/9711 (2017.08); A61K 8/9789 (2017.08); A61K 8/9794 (2017.08); A61K 9/06 (2013.01); A61K 9/107 (2013.01); A61K 31/704 (2013.01); A61K 31/734 (2013.01); A61K 36/23 (2013.01); A61K 36/28 (2013.01); A61K 36/33 (2013.01); A61K 36/88 (2013.01); A61K 36/896 (2013.01); A61K 38/011 (2013.01); A61K 38/16 (2013.01); A61Q 19/005 (2013.01); A61Q 19/08 (2013.01)]

10 Claims

1. A method of treating oxidatively damaged skin of a human in need thereof and/or enhancing skin tone of a human in need thereof, the method comprising topically applying to the oxidatively damaged skin and/or skin with uneven skin tone a composition comprising escin, Aesculus hippocastanum (horse chestnut) extract, fructose, butylene glycol, Butyrospermum parkii (shea) butter, glycerin, caprylic/capric triglyceride, dimethicone, and one or both of tocopherol and tocopheryl acetate, wherein oxidative damage in the skin is reduced and/or skin tone is evened.